Latest

AstraZeneca Faces Turbulence. Is Now the Time to Invest?

AstraZeneca Faces Turbulence. Is Now the Time to Invest?

December 22, 2024
AstraZeneca, one of the U.K.’s leading pharmaceutical companies, is currently grappling with significant challenges in China. Recent arrest of the company’s top executives, including Leon Wang, the president of AstraZeneca China, has cast a shadow over its operations in this vital market.
1 474 475 476 477 478 940